Shuttle Pharmaceuticals Holdings, Inc. Financial Overview
Shuttle Pharmaceuticals Holdings, Inc.'s market cap is currently $2.76M. The company's EPS TTM is $-3.248; its P/E ratio is -0.08; Shuttle Pharmaceuticals Holdings, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.